home / stock / nlnk / nlnk short
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,174,196 |
Total Actual Volume | 8,770,275 |
Short Trends | |
---|---|
Cover Days | 4 |
Short Days | 6 |
No Change Days | 10 |
Averages | |
---|---|
Average Short Volume | 58,710 |
Average Short Percentage | 43.92% |
Is there a NLNK Short Squeeze or Breakout about to happen?
See the NLNK Short Analysis for free Sign up or Login
Powered by Squeeze Report
Stock Date | Open Price | Close Price | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
2020-02-12 | 1.63 | 1.58 | 1.65 | 1.57 | 183,508 | 21,116 | 55.6153 |
2020-02-11 | 1.63 | 1.62 | 1.64 | 1.56 | 185,803 | 17,688 | 33.6267 |
2020-02-10 | 1.65 | 1.61 | 1.67 | 1.57 | 298,310 | 24,088 | 28.2620 |
2020-02-07 | 1.75 | 1.66 | 1.75 | 1.64 | 302,819 | 26,545 | 35.5051 |
2020-02-06 | 1.74 | 1.75 | 1.7636 | 1.71 | 237,213 | 25,148 | 46.4165 |
2020-02-05 | 1.76 | 1.75 | 1.78 | 1.68 | 305,280 | 50,511 | 51.7160 |
2020-02-04 | 1.68 | 1.74 | 1.77 | 1.66 | 628,781 | 129,356 | 58.8544 |
2020-02-03 | 1.69 | 1.66 | 1.78 | 1.62 | 350,412 | 55,685 | 51.5540 |
2020-01-31 | 1.63 | 1.64 | 1.67 | 1.56 | 509,952 | 60,281 | 44.2878 |
2020-01-30 | 1.65 | 1.63 | 1.6694 | 1.58 | 390,862 | 44,069 | 37.9251 |
2020-01-29 | 1.73 | 1.65 | 1.75 | 1.63 | 425,883 | 42,027 | 35.7130 |
2020-01-28 | 1.72 | 1.72 | 1.83 | 1.67 | 425,682 | 62,813 | 42.1949 |
2020-01-27 | 1.74 | 1.71 | 1.82 | 1.71 | 459,260 | 69,759 | 48.7392 |
2020-01-24 | 2.00 | 1.82 | 2.01 | 1.82 | 591,347 | 61,085 | 47.2908 |
2020-01-23 | 2.03 | 2.00 | 2.03 | 1.94 | 333,206 | 27,997 | 24.8361 |
2020-01-22 | 2.30 | 2.04 | 2.33 | 2.01 | 662,357 | 76,078 | 37.4996 |
2020-01-21 | 2.04 | 2.26 | 2.40 | 2.04 | 1,210,301 | 171,477 | 48.1221 |
2020-01-17 | 1.99 | 2.04 | 2.08 | 1.9301 | 681,501 | 134,382 | 67.8289 |
2020-01-16 | 1.97 | 1.99 | 2.10 | 1.94 | 287,269 | 47,075 | 50.1112 |
2020-01-15 | 1.98 | 1.99 | 2.0583 | 1.93 | 300,529 | 27,016 | 32.3173 |
NewLink Genetics Corporation Company Name:
NLNK Stock Symbol:
NASDAQ Market:
NewLink Genetics Corporation Website:
News, Short Squeeze, Breakout and More Instantly...
Kahn Swick & Foti, LLC Announces Summary Notice of Proposed Settlement Involving Purchasers of NewLink Common Stock Kahn Swick & Foti, LLC Announces Summary Notice of Proposed Settlement Involving Purchasers of NewLink Common Stock PR Newswire NEW ORLEANS ...
AUSTIN, Texas, March 30, 2020 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, has announced the appointment of Joseph S. McCracken, DVM, MS to the company's Board of Directors, effective March 23...
- Combined company, Lumos Pharma, Inc., to trade on Nasdaq under the stock symbol “LUMO” - Phase 2b trial expected to be initiated mid-2020 evaluating oral therapeutic candidate LUM-201 (ibutamoren) in Pediatric Growth Hormone Deficiency (PGHD) - Projected combined cash ...